Chatham Capital Group, Inc. Abbott Laboratories Transaction History

Chatham Capital Group, Inc.

$601 Million
Q3 2024

A detailed history of Chatham Capital Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Chatham Capital Group, Inc. holds 8,642 shares of ABT stock, worth $1.03 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

8,642

Previous 8,642 -0.0%

Holding current value

$1.03 Million

Previous $897,000 9.81%

% of portfolio

0.16%

Previous 0.16%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$100.73 - $112.44 $40,292 - $44,976	-400 Reduced 4.42%	8,642 $897,000
Q1 2024 Apr 17, 2024	BUY	$109.52 - $120.96 $4,380 - $4,838	40 Added 0.44%	9,042 $1.03 Million
Q3 2023 Oct 25, 2023	SELL	$95.53 - $114.62 $713,131 - $855,638	-7,465 Reduced 45.33%	9,002 $871,000
Q2 2023 Jul 13, 2023	BUY	$100.78 - $112.29 $752,322 - $838,244	7,465 Added 82.93%	16,467 $1.8 Million
Q4 2022 Jan 31, 2023	SELL	$95.06 - $111.52 $764,757 - $897,178	-8,045 Reduced 47.19%	9,002 $988,000
Q3 2022 Oct 28, 2022	BUY	$96.76 - $112.03 $4,838 - $5,601	50 Added 0.29%	17,047 $1.65 Million
Q2 2022 Aug 02, 2022	SELL	$102.07 - $123.37 $306 - $370	-3 Reduced 0.02%	16,997 $1.85 Million
Q4 2021 Feb 02, 2022	SELL	$115.53 - $141.46 $69,318 - $84,876	-600 Reduced 3.41%	17,000 $2.39 Million
Q2 2021 Jul 28, 2021	BUY	$105.79 - $124.53 $40,200 - $47,321	380 Added 2.21%	17,600 $2.04 Million
Q1 2021 Apr 29, 2021	SELL	$108.84 - $128.23 $11,537 - $13,592	-106 Reduced 0.61%	17,220 $2.06 Million
Q4 2020 Jan 27, 2021	BUY	$105.0 - $114.42 $128,625 - $140,164	1,225 Added 7.61%	17,326 $1.9 Million
Q2 2020 Jul 20, 2020	SELL	$76.57 - $98.0 $141,654 - $181,300	-1,850 Reduced 10.31%	16,101 $1.47 Million
Q1 2020 May 01, 2020	SELL	$62.82 - $91.86 $63,196 - $92,411	-1,006 Reduced 5.31%	17,951 $1.42 Million
Q4 2019 Jan 31, 2020	SELL	$78.51 - $87.4 $3,140 - $3,496	-40 Reduced 0.21%	18,957 $1.65 Million
Q3 2019 Nov 08, 2019	SELL	$81.84 - $88.74 $24,552 - $26,622	-300 Reduced 1.55%	18,997 $1.59 Million
Q2 2019 Jul 24, 2019	SELL	$72.88 - $85.0 $15,523 - $18,105	-213 Reduced 1.09%	19,297 $1.62 Million
Q3 2018 Oct 30, 2018	SELL	$60.81 - $73.36 $6,081 - $7,336	-100 Reduced 0.51%	19,510 $1.43 Million
Q2 2018 Jul 30, 2018	SELL	$57.57 - $63.54 $40,299 - $44,478	-700 Reduced 3.45%	19,610 $1.2 Million
Q1 2018 May 09, 2018	SELL	$56.27 - $63.62 $5,627 - $6,362	-100 Reduced 0.49%	20,310 $1.22 Million
Q4 2017 Feb 01, 2018	SELL	$53.68 - $57.47 $29,524 - $31,608	-550 Reduced 2.62%	20,410 $1.17 Million
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $1,201 - $1,341	25 Added 0.12%	20,960 $1.12 Million
Q2 2017 Aug 09, 2017	BUY	N/A	20,935	20,935 $1.02 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chatham Capital Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chatham Capital Group, Inc. with notifications on news.

Account

Chatham Capital Group, Inc. Abbott Laboratories Transaction History